B. Wängler

Oxalic acid supported Si-18F-radiofluorination: one-step radiosynthesis of N-succinimidyl 3-(di-tert-butyl[18F]fluorosilyl)benzoate ([18F]SiFB) for protein labeling.

K. Jurkschat, A. Aliaga, H. Wester, 2012, Bioconjugate chemistry.

18F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals

K. Jurkschat, R. Schirrmacher, C. Wängler, 2014, BioMed research international.

Next Step toward Optimization of GRP Receptor Avidities: Determination of the Minimal Distance between BBN(7-14) Units in Peptide Homodimers.

S. Lindner, G. Fischer, R. Schirrmacher, 2015, Bioconjugate chemistry.

Automated radiosynthesis of N-succinimidyl 3-(di-tert-butyl[(18)F]fluorosilyl)benzoate ([(18)F]SiFB) for peptides and proteins radiolabeling for positron emission tomography.

K. Jurkschat, R. Schirrmacher, C. Wängler, 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics

P. Bartenstein, A. Gosewisch, H. Ilhan, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Rapid (18)F-labeling and loading of PEGylated gold nanoparticles for in vivo applications.

Ralf Schirrmacher, Joshua Chin, Carmen Wängler, 2014, Bioconjugate chemistry.

Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model.

A. Bhardwaj, M. Wuest, F. Wuest, 2021, Journal of medicinal chemistry.

18F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals

K. Jurkschat, R. Schirrmacher, C. Wängler, 2014, BioMed research international.

Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE.

M. Fabritius, C. Wängler, A. Holzgreve, 2024, European radiology.

PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.

K. Jurkschat, N. Albert, J. Tonn, 2021, Clinical nuclear medicine.